Company · CIK 1868279
ArriVent BioPharma, Inc.
| CIK | 1868279 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | PA |
| Listed | AVBP (Nasdaq) |
| First annual or quarterly report | 2024-03-28 |
Offerings
2 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-284661 | 2025-02-03 | 2026-05-11 | 4 | |
| 333-276397 | 2024-01-05 | 2024-01-26 | 5 |
Filings
10| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-05-11 | 424B5Shelf takedown | 333-284661 | 0001104659-26-058700 |
| 2025-07-02 | 424B5Shelf takedown | 333-284661 | 0001104659-25-065391 |
| 2025-07-01 | 424B5Shelf takedown | 333-284661 | 0001104659-25-064736 |
| 2025-02-03 | S-3ASRShelf registered | 333-284661 | 0001104659-25-008356 |
| 2024-01-26 | 424B4Final prospectus | 333-276397 | 0001104659-24-007261 |
| 2024-01-25 | EFFECTDeclared effective | 333-276397 | 9999999995-24-000212 |
| 2024-01-23 | S-1/AAmendment | 333-276397 | 0001104659-24-005933 |
| 2024-01-22 | S-1/AAmendment | 333-276397 | 0001104659-24-005364 |
| 2024-01-05 | S-1Registration filed | 333-276397 | 0001104659-24-001804 |
| 2023-08-25 | DRSDraft made public | 377-06842 | 0001104659-23-095379 |